Donald McCaffrey
Chief Executive Officer at RESVERLOGIX CORP.
Net worth: 613 356 $ as of 2024-03-30
Network origin in Donald McCaffrey first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
| Public Company | Biotechnology | 10 | |
| Subsidiary | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Donald McCaffrey via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| QUEST PHARMATECH INC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| SERNOVA CORP. | Biotechnology | Director/Board Member Director/Board Member | |
Molecular Medicine BioServices, Inc.
 Molecular Medicine BioServices, Inc. Pharmaceuticals: MajorHealth Technology Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015. | Pharmaceuticals: Major | Sales & Marketing | |
| CATHEDRAL ENERGY SERVICES LTD. | Contract Drilling | Director/Board Member | |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| Rising Sky Energy Ltd. | Director/Board Member | ||
Vivaldi Biosciences, Inc.
 Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Director/Board Member | |
| KARNALYTE RESOURCES INC. | Other Metals/Minerals | Director/Board Member | |
| BONAVISTA ENERGY CORPORATION | Oil & Gas Production | Director/Board Member | |
TSX Venture Exchange, Inc.
 TSX Venture Exchange, Inc. Investment ManagersFinance TSX Venture Exchange, Inc. provides capital and financial services to early stage companies. It offers an access to capital and a market for making venture investments. The firm also provides corporate finance, business development and compliance, and disclosure services. The company was founded on November 29, 1999 and is headquartered in Calgary, Canada. | Investment Managers | Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Alberta | College/University | Graduate Degree Undergraduate Degree | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
| University of Western Ontario | College/University | Undergraduate Degree Doctorate Degree | |
| McMaster University | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree Graduate Degree | |
| University of Manitoba | College/University | Undergraduate Degree Graduate Degree | |
| Technische Universität München | College/University | Doctorate Degree | |
| University of Calgary | College/University | Undergraduate Degree Corporate Officer/Principal President Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Moody's Analytics Global Education (Canada), Inc.
 Moody's Analytics Global Education (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Moody's Analytics Global Education (Canada), Inc. provides financial education and testing services. It offers courses in retail banking, financial planning, CE courses, seminars, study tools, and corporate solutions. The company was founded in 1970 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Canadian Investor Protection Fund
 Canadian Investor Protection Fund Miscellaneous Commercial ServicesCommercial Services Canadian Investor Protection Fund engages in providing investment services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman Director/Board Member | |
Origin Capital Management Ltd.
 Origin Capital Management Ltd. Investment ManagersFinance Origin Capital Management Ltd. is a private company based in Calgary, Canada. and has subsidiaries in Canada. The Canadian company was founded by Donald Larry Short. | Investment Managers | Director/Board Member | |
| IMV INC. | Biotechnology | Director/Board Member Director/Board Member | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
The Chartered Professional Accountants of British Columbia
 The Chartered Professional Accountants of British Columbia Miscellaneous Commercial ServicesCommercial Services The Chartered Professional Accountants of British Columbia is an association of accountants based in Vancouver, Canada. and has subsidiaries in Australia. The Canadian company operates as an association of accountants. The CEO of the private company is Lori Mathison. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lumendi Ltd.
 Lumendi Ltd. Medical SpecialtiesHealth Technology Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014. | Medical Specialties | Chief Executive Officer | |
| ENVERIC BIOSCIENCES, INC. | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member |
Statistics
International
| Canada | 26 |
| United States | 16 |
| Germany | 5 |
| Switzerland | 4 |
| Sweden | 2 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 6 |
| Energy Minerals | 3 |
Operational
| Director/Board Member | 178 |
| Corporate Officer/Principal | 79 |
| Independent Dir/Board Member | 49 |
| Chairman | 43 |
| President | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Julie Cherrington | 32 |
| Arthur Higgins | 29 |
| Eldon Smith | 29 |
| Ian S. Brown | 26 |
| William A. Cochrane | 21 |
| Peter Johann | 18 |
| Stella M. Thompson | 18 |
| Don B. Rix | 18 |
| Bradley Thompson | 17 |
| Siu Lun To | 15 |
| Shawn Lu | 14 |
| Roger S. Newton | 14 |
| Joseph Tucker | 13 |
| James DeMesa | 13 |
| Kenneth Zuerblis | 12 |
- Stock Market
- Insiders
- Donald McCaffrey
- Company connections
